Prostate Specific Antigen (PSA) Testing Market Research Report: Market size, Industry outlook, Market Forecast, Demand Analysis,Market Share, Market Report 2018-2023
  • 1-614-588-8538 (Ext: 101)
  • US Toll Free

Prostate specific antigen market
Prostate Specific Antigen (PSA) Testing Market: By test type (Preliminary-tests,(Total prostate Specific Antigen Test (tPSA), Free Prostate Specific Antigen Test (fPSA), Complex Prostate Specific Antigen Test (cPSA), Prostate Specific Antigen Reverse Transcription Polymerase chain reaction test (PSA RT-PCR)),Confirmatory-tests( PCA3Test,Trans-rectal Ultrasound, Biopsy)), By assays type (Radioimmunoassay (RIA), Enzyme Immunoassay (EIA)) & Geography (North America, Europe, Asia Pacific, South America, Middle East & Africa) - Forecast(2018-2023)
Report Code : HCR 0038
Updated Date: 19 December, 2018  
5

Copies sold

    Client Rating

1. Prostate Specific Antigen Testing Market - Overview
1.1. Definitions and Scope
2. Prostate Specific Antigen Testing Market - Executive summary
2.1. Market Revenue, Market Size and Key Trends by Company
2.2. Key Trends by type of Application
2.3. Key Trends segmented by Geography
3. Prostate Specific Antigen Testing Market 
3.1. Comparative analysis
3.1.1. Product Benchmarking - Top 10 companies
3.1.2. Top 5 Financials Analysis
3.1.3. Market Value split by Top 10 companies
3.1.4. Patent Analysis - Top 10 companies
3.1.5. Pricing Analysis 
4. Prostate Specific Antigen Testing Market– Startup companies Scenario
4.1. Top 10 startup company Analysis by
4.1.1. Investment
4.1.2. Revenue
4.1.3. Market Shares
4.1.4. Market Size and Application Analysis
4.1.5. Venture Capital and Funding Scenario
5. Prostate Specific Antigen Testing Market– Industry Market Entry Scenario
5.1. Regulatory Framework Overview
5.2. New Business and Ease of Doing business index
5.3. Case studies of successful ventures
5.4. Customer Analysis – Top 10 companies
6. Prostate Specific Antigen Testing Market Forces
6.1. Drivers
6.2. Constraints
6.3. Challenges
6.4. Porters five force model
6.4.1. Bargaining power of suppliers
6.4.2. Bargaining powers of customers
6.4.3. Threat of new entrants
6.4.4. Rivalry among existing players
6.4.5. Threat of substitutes 
7. Prostate Specific Antigen Testing Market -Strategic analysis
7.1. Value chain analysis
7.2. Opportunities analysis
7.3. Product life cycle
8. Prostate Specific Antigen Testing Market– By Test type (Market Size -$Million / $Billion)
8.1. Market Size and Market Share Analysis 
8.2. Service Revenue and Trends by type of test
8.3. Service Segment Analysis   by test type
8.3.1. Preliminary tests
8.3.1.1. Total Prostate Specific Antigen Test
8.3.1.2. Complex Prostate Specific Antigen Test
8.3.1.3. Free Prostate Specific Antigen Test
8.3.1.4. Prostate Specific Antigen Reverse Transcription Polymerase Chain Reaction Test
8.3.2. Confirmatory tests
8.3.2.1. PCA3Test
8.3.2.2. Trans-rectal Ultrasound
8.3.2.3. Biopsy
9. Prostate Specific Antigen Testing Market– By Assays type (Market Size -$Million / $Billion)
9.1. Radioimmunoassay (RIA)
9.2. Enzyme Immunoassay (EIA)
10. Prostate Specific Antigen Testing Market- By Geography (Market Size -$Million / $Billion)
10.1. Prostate Specific Antigen Testing Market - North America Segment Research
10.2. North America Market Research (Million / $Billion)
10.2.1. Segment type Size and Market Size Analysis 
10.2.2. Revenue and Trends
10.2.3. Application Revenue and Trends by type of Application
10.2.4. Company Revenue and Product Analysis
10.2.5. North America Product type and Application Market Size
10.2.5.1. U.S.
10.2.5.2. Canada 
10.2.5.3. Mexico 
10.2.5.4. Rest of North America
10.3. Prostate Specific Antigen Testing Market- South America Segment Research
10.4. South America Market Research (Market Size -$Million / $Billion)
10.4.1. Segment type Size and Market Size Analysis 
10.4.2. Revenue and Trends
10.4.3. Application Revenue and Trends by type of Application
10.4.4. Company Revenue and Product Analysis
10.4.5. South America Product type and Application Market Size
10.4.5.1. Brazil  
10.4.5.2. Venezuela
10.4.5.3. Argentina
10.4.5.4. Ecuador
10.4.5.5. Peru
10.4.5.6. Colombia 
10.4.5.7. Costa Rica
10.4.5.8. Rest of South America
10.5. Prostate Specific Antigen Testing Market- Europe Segment Research
10.6. Europe Market Research (Market Size -$Million / $Billion)
10.6.1. Segment type Size and Market Size Analysis 
10.6.2. Revenue and Trends
10.6.3. Application Revenue and Trends by type of Application
10.6.4. Company Revenue and Product Analysis
10.6.5. Europe Segment Product type and Application Market Size
10.6.5.1. U.K  
10.6.5.2. Germany 
10.6.5.3. Italy 
10.6.5.4. France
10.6.5.5. Netherlands
10.6.5.6. Belgium
10.6.5.7. Spain
10.6.5.8. Denmark
10.6.5.9. Rest of Europe
10.7. Prostate Specific Antigen Testing Market– APAC Segment Research
10.8. APAC Market Research (Market Size -$Million / $Billion)
10.8.1. Segment type Size and Market Size Analysis 
10.8.2. Revenue and Trends
10.8.3. Application Revenue and Trends by type of Application
10.8.4. Company Revenue and Product Analysis
10.8.5. APAC Segment – Product type and Application Market Size
10.8.5.1. China 
10.8.5.2. Australia
10.8.5.3. Japan 
10.8.5.4. South Korea
10.8.5.5. India
10.8.5.6. Taiwan
10.8.5.7. Malaysia
10.8.5.8. Hong Kong  
10.8.5.9. Rest of APAC
10.9. Prostate Specific Antigen Testing Market– Middle East Segment and Africa Segment Research
10.10. Middle East & Africa Market Research (Market Size -$Million / $Billion)
10.10.1. Segment type Size and Market Size Analysis 
10.10.2. Revenue and Trend Analysis
10.10.3. Application Revenue and Trends by type of Application 
10.10.4. Company Revenue and Product Analysis
10.10.5. Middle East Segment Product type and Application Market Size
10.10.5.1. Israel 
10.10.5.2. Saudi Arabia
10.10.5.3. UAE
10.10.6. Africa Segment Analysis
10.10.6.1. South Africa
10.10.6.2. Rest of Middle East & Africa
11. Prostate Specific Antigen Testing Market - Entropy
11.1. New product launches
11.2. M&A's, collaborations, JVs and partnerships
12. Prostate Specific Antigen Testing Market – Industry / Segment Competition landscape
12.1. Market Share Analysis
12.1.1. Market Share by Country- Top companies
12.1.2. Market Share by Region- Top 10 companies
12.1.3. Market Share by type of Application – Top 10 companies
12.1.4. Market Share by type of Product / Product category- Top 10 companies
12.1.5. Market Share at global level- Top 10 companies
12.1.6. Best Practices for companies
13. Prostate Specific Antigen Testing Market – Key Company List by Country
14. Prostate Specific Antigen Testing Market Company Analysis
14.1. Market Share, Company Revenue, Products, M&A, Developments
14.2. Abbott Laboratories Inc.
14.3. Bayer AG.
14.4. Beckman Coulter Inc.
14.5. GE Healthcare
14.6. GlaxoSmithKline plc.
14.7. Novartis Pharma AG.
14.8. UroLogix Inc.
14.9. Bristol - Myers Squibb Company
14.10. AstraZeneca plc. 
14.11. Company 10
14.12. Company 11
14.13. Company 12 and more
"*Financials would be provided on a best efforts basis for private companies"
15. Prostate Specific Antigen Testing Market -Appendix
15.1. Abbreviations
15.2. Sources
16. Prostate Specific Antigen Testing Market -Methodology
16.1. Research Methodology
16.1.1. Company Expert Interviews
16.1.2. Industry Databases
16.1.3. Associations
16.1.4. Company News
16.1.5. Company Annual Reports
16.1.6. Application Trends
16.1.7. New Products and Product database
16.1.8. Company Transcripts
16.1.9. R&D Trends
16.1.10. Key Opinion Leaders Interviews
16.1.11. Supply and Demand Trends
Please select Licence
Single User Licence:
US $5250
Corporate User Licence:
US $7250
Related Reports
0px;">Scroll